LAST PRICE - AT THE CLOSE
EMRAF is UP 14% since the begininning of the year
EMRAF is UP 3% ABOVE 20 day SMA
EMRAF is UP 14% ABOVE 200 day SMA
PROFITABLE: YES
EPS: $0.3721
EARNINGS MOMENTUM: N/A
N/A INCREASE IN QTRLY EARNINGS
P/E RATIO IS: 34.2893
INCOME TO DEBT RATIO: 0.03
 |
THE STOCK IS 18.6% AWAY FROM ALL-TIME HIGHS OF $52.56 |
 |
EMRAF IS UP 14% SINCE THE BEGINNING OF THE YEAR |
 |
EMRAF IS UP 24% OVER THE PAST 12 MONTHS |
 |
EMRAF IS UP 4% OVER THE PAST 1 MONTH |
 |
1% OF ALL EMRAF INVESTORS ARE BETTING AGAINST EMRAF |
 |
NUM INVESTORS SHORT EMRAF HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|---|---|
 | Currently at 1 x ave... | 04/11 |
 | Crossed above open a... | 04/11 |
 | New 60 minute high. | 04/11 |
 | New 60 minute low. | 04/11 |
 | Opening range breako... | 04/11 |
 |
EMRAF moved up 0 in the previous minute |
 |
EMRAF is up 0.7 over the last hour |
 |
EMRAF is up 0.2% over the last 5 days |
 |
EMRAF is 0.8 above its 8 day SMA |
| $42.46 |   DAY |
$42.77 |
| $40.07 |  PREVIOUS DAY |
$40.77 |
| $39.19 | WEEK |
$44.11 |
| $39.19 | MONTH |
$44.11 |
| $32.00 | YEAR |
$44.11 |
EMRAF is mentioned N/A less than normal on 
EMRAF is mentioned N/A times in an average day on 
